Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. (ENXTPA:ALM) agreed to acquire 10% stake in Alpha MOS S.A. (ENXTPA:ALM) from Diagnostic Medical Systems S.A. (ENXTPA:DGM) for 0.9 million on November 16, 2015. Jean-Christophe Mifsud acquired 2.3 million shares of Alpha MOS S.A. for 0.4 per share.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.728 EUR | +0.28% | +2.54% | -12.71% |
04-25 | Alpha MOS: share price advances on 'positive' outlook | CF |
04-25 | Alpha MOS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.71% | 20.35M | |
+12.06% | 227B | |
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.19% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B |
- Stock Market
- Equities
- ALNEO Stock
- News Alpha MOS
- Jean-Christophe Mifsud, Chief Executive Officer of Alpha MOS S.A. agreed to acquire 10% stake in Alpha MOS S.A. for €0.9 million.